Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-29

FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., confirming regulatory clearance for an updated product-related indication, for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen sodium (naproxen sodium)

Snippet

SUPPL AP for NAPROXEN SODIUM (NAPROXEN SODIUM)